BCL2 and diabetes mellitus: BRD7 inhibition effectively ameliorated diabetes‐induced CHOP expression (P < 0.05; Fig. 2A and B), ratio of Bax/Bcl‐2 (P < 0.05; Fig. 2C) and caspase‐3 activity (P < 0.05; Fig. 2D).